Second, we focused on two specific SNPs in the PDCD1 and LAG3 genes, but additional genetic variations or haplotype analyses may provide further insights into the potential role of these immune checkpoint genes in AML susceptibility and prognosis. This evidence concerns the gene PDCD1 and acute myeloid leukemia.